Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy
Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy
Recruiting · NCT06020430 · Registry updated 2024-03-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Not applicable | 2024-03-15 | NCT06020430 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hubei Cancer Hospital | 29 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hubei Cancer Hospital | Wuhan | China | 95 |